We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New DNA-Based Assay Rapidly Detects E. coli O157:H7 During Food Manufacture

By LabMedica International staff writers
Posted on 18 Nov 2015
A rapid DNA-based test for the detection of the serious food borne pathogen E. More...
coli O157:H7 joins a line of innovative assays designed for use by the food industry.

The ANSR E. coli O157:H7 kit is a welcome addition to Neogen Corporation’s (Lansing, MI, USA) ANSR tests for Salmonella, Listeria, and Listeria monocytogenes.

Neogen's ANSR (Amplified Nucleic Single Temperature Reaction) platform incorporates advances in DNA detection technology resulting in a method that is easy to use and provides much faster results than PCR systems. ANSR was designed to address in-plant testing needs and offers the freedom to economically process samples to meet regulatory requirements and ensure food safety.

ANSR uses isothermal amplification to create a level of molecular target material that can be detected using fluorescence. The system's DNA amplification methodology exponentially amplifies the DNA of any target bacteria present in an enriched food sample to detectable levels in only minutes. Target nucleic acid is amplified through a mechanism of polymerization from the ends of nicks created in double-stranded DNA by the action of a specific endonuclease. Amplified target sequences are detected in real time using fluorescent molecular beacon probes.

To date, the assay has been validated for testing raw ground beef, raw beef trim, leafy greens, and sprout irrigation water. The system has exhibited low matrix effects with high sensitivity and provides both positive and negative results in minutes.

"The well-received and validated ANSR system provides the food industry definitive test results, and much easier and quicker methodology," said Ed Bradley, vice president of food safety at Neogen. "This introduction of ANSR for E. coli O157:H7 extends our ANSR product offering for the bacterial pathogens of greatest concern to the food industry, and will be very easy for laboratories to adopt, as it follows the same procedure of all our other ANSR kits."

Related Links:

Neogen Corporation 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Automated Clinical Chemistry Analyzer
Envoy 500+
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.